ImmunoconjugatesAntigens, CD30Hodgkin DiseaseLymphoma, Non-HodgkinLymphoma, Large-Cell, AnaplasticCardiotoxinsRecurrenceLymphoma, Primary EffusionLymphomaSalvage TherapyPeripheral Nervous System DiseasesClinical Trials, Phase I as TopicHematologic NeoplasmsAntineoplastic AgentsLymphoma, B-CellHematopoietic Stem Cell TransplantationOligopeptidesLymphoma, T-CellReed-Sternberg CellsLymphoma, Large B-Cell, DiffuseTreatment OutcomeLymphoma, FollicularBurkitt LymphomaLymphoma, B-Cell, Marginal ZoneLymphoma, Mantle-CellLymphoma, AIDS-RelatedLymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralVincristineAnemia, RefractoryPrednisoneAntineoplastic Combined Chemotherapy ProtocolsRefractory Period, ElectrophysiologicalAntibodies, Monoclonal, Murine-DerivedBleomycinDoxorubicinAntigens, CD20Herpesvirus 4, HumanLymphoma, Large-Cell, ImmunoblasticEpstein-Barr Virus InfectionsCyclophosphamideProcarbazineRemission InductionVinblastineEtoposideB-LymphocytesImmunophenotypingImmunohistochemistryPrognosisDacarbazineTranslocation, GeneticAntibodies, MonoclonalTransplantation, AutologousRetrospective StudiesAnemia, Refractory, with Excess of BlastsCombined Modality TherapyLymph NodesDisease-Free SurvivalMediastinal NeoplasmsSurvival RateLymphoma, Extranodal NK-T-CellSurvival Analysis